Knowledge Content Library
Simulation of the Portfolio of COVID-19 Vaccines
Pharma Interest Group Meeting: Speakers: Vladimir Shnaydman and Jack Scannell
May 21, 2020
Vladimir and Jack discuss the use of probabilistic methods and simulation to explore the likelihood of success of the portfolio of COVID-19 vaccination efforts underway around the world.
Click here for access to the full video.
SDP membership is required for full access to this presentation.
Keywords: Risk and Uncertainty riskunc, Risk analysis riskanal, Analysis and modeling anamod, Probability assessment probass, Monte Carlo simulation mcsim, portfolio decision analysis portda